Damaged cardiac tissue post-acute myocardial infarction

Damaged cardiac tissue post-acute myocardial infarction (AMI) refers to the pathological state of the heart muscle following prolonged ischemia and subsequent cardiomyocyte death. According to StatPearls (PMID: 30725703), this process initiates with coagulative necrosis, followed by a robust inflammatory response where neutrophils and macrophages clear cellular debris. Over time, the tissue undergoes a remodeling process where the necrotic area is replaced by a non-contractile collagenous scar, a process known as fibrosis. This structural change often leads to adverse ventricular remodeling, which significantly increases the risk of heart failure and cardiac arrhythmias (PubMed: 31553215). While not a single molecular target, this damaged tissue environment is the primary focus of pharmacological interventions—such as ACE inhibitors, beta-blockers, and mineralocorticoid receptor antagonists—aimed at preserving left ventricular function and improving survival. Furthermore, the infarcted region is a major area of interest for regenerative medicine, including stem cell therapy and tissue engineering, which seek to restore functional myocardium (NIH/NHLBI).

Other names

Infarcted myocardiumMyocardial scarPost-MI cardiac tissueIschemic heart tissueNecrotic myocardium

Therapeutic management focuses on restoring coronary blood flow through thrombolysis or angioplasty, reducing myocardial oxygen demand via beta-blockade, and inhibiting the renin-angiotensin-aldosterone system to prevent adverse structural remodeling of the ventricular wall.